Literature DB >> 22350675

Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?

Gabriele Franken1, Irmela Müller-Stöver, Martha C Holtfreter, Susanne Walter, Heinz Mehlhorn, Alfons Labisch, Dieter Häussinger, Joachim Richter.   

Abstract

Quartan malaria due to Plasmodium malariae is commonly regarded as being preventable by current antimalarials. A case of P. malariae infection occurred in spite of previous treatment of Plasmodium falciparum malaria 4 months earlier with a full therapy course of intravenous quinine hydrochloride and oral doxycycline followed by artemether + lumefantrine. Since the patient was not anymore exposed to agents of malaria in the meantime, a new infection by P. malariae after therapy is unlikely. The present observation is difficult to explain by the current view on the origin of latent P. malariae infections and recurrences which are thought to arise from intra-erythrocytic development stages susceptible to common antimalarials. The most likely explanation of our observation is a delayed pre-erythrocytic development. The latency between infection by P. malariae and the quartan malaria fever attack might have been extended further by an initial subclinical circulation of a low number of intra-erythrocytic asexual parasites in the blood stream preceeding the clinical quartan malaria breakthrough.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350675     DOI: 10.1007/s00436-012-2851-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  28 in total

Review 1.  The hypnozoite concept, with particular reference to malaria.

Authors:  Miles B Markus
Journal:  Parasitol Res       Date:  2010-10-06       Impact factor: 2.289

2.  A LONG-DELAYED PRIMARY ATTACK OF OVALE MALARIA.

Authors:  W TRAGER; H MOST
Journal:  Am J Trop Med Hyg       Date:  1963-11       Impact factor: 2.345

3.  Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note.

Authors:  W A Krotoski; D M Krotoski; P C Garnham; R S Bray; R Killick-Kendrick; C C Draper; G A Targett; M W Guy
Journal:  Br Med J       Date:  1980-01-19

4.  Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.

Authors:  B Høgh; P D Clarke; D Camus; H D Nothdurft; D Overbosch; M Günther; I Joubert; K C Kain; D Shaw; N S Roskell; J D Chulay
Journal:  Lancet       Date:  2000-12-02       Impact factor: 79.321

5.  Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.

Authors:  Mallika Imwong; Georges Snounou; Sasithon Pukrittayakamee; Naowarat Tanomsing; Jung Ryong Kim; Amitab Nandy; Jean-Paul Guthmann; Francois Nosten; Jane Carlton; Sornchai Looareesuwan; Shalini Nair; Daniel Sudimack; Nicholas P J Day; Timothy J C Anderson; Nicholas J White
Journal:  J Infect Dis       Date:  2007-02-26       Impact factor: 5.226

6.  P. falciparum malaria recrudescence in a cancer patient.

Authors:  E Foca; R Zulli; F Buelli; M De Vecchi; A Regazzoli; F Castelli
Journal:  Infez Med       Date:  2009-03

7.  Plasmodium malariae infection in spite of previous anti-malarial medication.

Authors:  Irmela Müller-Stöver; Jaco J Verweij; Barbara Hoppenheit; Klaus Göbels; Dieter Häussinger; Joachim Richter
Journal:  Parasitol Res       Date:  2007-12-02       Impact factor: 2.289

Review 8.  Plasmodium malariae: parasite and disease.

Authors:  William E Collins; Geoffrey M Jeffery
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

9.  Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival.

Authors:  Lena Hulden; Larry Hulden
Journal:  Malar J       Date:  2011-04-16       Impact factor: 2.979

10.  Falciparum malaria in patient 9 years after leaving malaria-endemic area.

Authors:  Caroline Theunissen; Peter Janssens; Anne Demulder; Denis Nouboussié; Marjan Van-Esbroeck; Alfons Van-Gompel; Jef Van-Denende
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more
  8 in total

1.  Renal cortical necrosis and acute kidney injury associated with Plasmodium vivax: a neglected human malaria parasite.

Authors:  Vivek B Kute; Aruna V Vanikar; Pramod P Ghuge; Jitendra G Goswami; Mohan P Patel; Himanshu V Patel; Manoj R Gumber; Pankaj R Shah; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2012-06-06       Impact factor: 2.289

2.  High prevalence and genetic diversity of Plasmodium malariae and no evidence of Plasmodium knowlesi in Bangladesh.

Authors:  Hans-Peter Fuehrer; Paul Swoboda; Josef Harl; Peter Starzengruber; Verena Elisabeth Habler; Ingrid Bloeschl; Rashidul Haque; Julia Matt; Wasif Ali Khan; Harald Noedl
Journal:  Parasitol Res       Date:  2014-02-28       Impact factor: 2.289

Review 3.  Clinical implications of a gradual dormancy concept in malaria.

Authors:  Joachim Richter; Gabriele Franken; Martha C Holtfreter; Susanne Walter; Alfons Labisch; Heinz Mehlhorn
Journal:  Parasitol Res       Date:  2016-04-15       Impact factor: 2.289

4.  Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon.

Authors:  Ghyslain Mombo-Ngoma; Christian Kleine; Arti Basra; Heike Würbel; Daisy A Diop; Mesküre Capan; Ayola A Adegnika; Florian Kurth; Benjamin Mordmüller; Fanny Joanny; Peter G Kremsner; Michael Ramharter; Sabine Bélard
Journal:  Malar J       Date:  2012-07-10       Impact factor: 2.979

5.  Recrudescence of Plasmodium malariae after Quinine.

Authors:  Irfanali R Kugasia; Farhana K Polara; Hussein Assallum
Journal:  Case Rep Med       Date:  2014-02-12

6.  Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.

Authors:  Beatrix Huei-Yi Teo; Paul Lansdell; Valerie Smith; Marie Blaze; Debbie Nolder; Khalid B Beshir; Peter L Chiodini; Jun Cao; Anna Färnert; Colin J Sutherland
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

7.  Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine.

Authors:  Gavin G Rutledge; Ian Marr; G Khai Lin Huang; Sarah Auburn; Jutta Marfurt; Mandy Sanders; Nicholas J White; Matthew Berriman; Chris I Newbold; Nicholas M Anstey; Thomas D Otto; Ric N Price
Journal:  Emerg Infect Dis       Date:  2017-08-15       Impact factor: 6.883

8.  Clinical Sequelae Associated with Unresolved Tropical Splenomegaly in a Cohort of Recently Resettled Congolese Refugees in the United States-Multiple States, 2015-2018.

Authors:  Laura Divens Zambrano; Emily Jentes; Christina Phares; Michelle Weinberg; S Patrick Kachur; Mukunda Singh Basnet; Alexander Klosovsky; Moses Mwesigwa; Marwan Naoum; Samuel Lubwama Nsobya; Olivia Samson; Matthew Goers; Robert McDonald; Bozena Morawski; Henry Njuguna; Corey Peak; Rebecca Laws; Yasser Bakhsh; Sally Ann Iverson; Carla Bezold; Hayder Allkhenfr; Roberta Horth; Jun Yang; Susan Miller; Michael Kacka; Abby Davids; Margaret Mortimer; William Stauffer; Nina Marano
Journal:  Am J Trop Med Hyg       Date:  2020-04-30       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.